Buy Takhzyro (lanadelumab) Online For Sale
£10,390.25
DISEASE INDICATIONS: Hereditary angioedema (HAE)
MANUFACTURER: Shire Pharmaceuticals
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Takhzyro is the brand name for the medication with the active ingredient lanadelumab. It is a prescription drug used for the prevention of hereditary angioedema (HAE) attacks in patients aged 12 years and older.